Changes of blood pressure and left ventricular mass in pediatric renal transplantation

Erwin Kitzmueller1, Andreas Vécsei, Judith Pichler

  • 1Department of Pediatrics, AKH Wien, Vienna, Austria.

Insights

Blood pressure control is crucial for maintaining heart structure in children post-kidney transplant. Managing arterial hypertension and monitoring left ventricular mass index are key to preventing long-term cardiovascular issues.

Area of Science:

  • Pediatric Nephrology
  • Cardiology
  • Transplantation Medicine

Background:

  • Cardiovascular events are a major cause of morbidity and mortality in pediatric renal transplant recipients.
  • Arterial hypertension and left ventricular hypertrophy are highly prevalent in this population.
  • Understanding the impact of blood pressure on cardiac structure is vital for long-term outcomes.

Purpose of the Study:

  • To investigate the effects of post-transplant arterial hypertension, assessed by 24-hour ambulatory blood pressure monitoring (ABPM), on myocardial architecture.
  • To analyze the longitudinal relationship between blood pressure control and left ventricular mass index (LVMI) in children after renal transplantation.

Main Methods:

  • Retrospective chart review of 39 pediatric renal transplant recipients.
  • Assessment of 24-hour ABPM and echocardiography within 3 months post-transplantation.
  • Longitudinal analysis of 20 patients with repeated measurements after a mean follow-up of 2 years.

Main Results:

  • High prevalence of arterial hypertension (59%) and left ventricular hypertrophy (50%) was observed.
  • Initially, renal allograft function and medication count correlated with LVMI, not ABPM.
  • At follow-up, significant correlations emerged between ABPM and LVMI, influenced by cyclosporine dosage and blood pressure changes.

Conclusions:

  • Blood pressure control is directly correlated with changes in left ventricular mass index in pediatric renal allograft recipients.
  • Maintaining optimal blood pressure is essential for preserving myocardial architecture and reducing cardiovascular risk.
  • Longitudinal monitoring of ABPM and cardiac structure is recommended for these patients.